Lyra Therapeutics Statistics

Total Valuation

LYRA has a market cap or net worth of $17.21 million. The enterprise value is -$13.54 million.

Market Cap	17.21M
Enterprise Value	-13.54M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, after market close.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

LYRA has 65.46 million shares outstanding. The number of shares has increased by 60.70% in one year.

Shares Outstanding	65.46M
Shares Change (YoY)	+60.70%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	21.59%
Float	41.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.96
Forward PS	18.22
PB Ratio	0.56
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 1.19.

Current Ratio	3.60
Quick Ratio	3.50
Debt / Equity	1.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -156.52% and return on invested capital (ROIC) is -55.53%.

Return on Equity (ROE)	-156.52%
Return on Assets (ROA)	-42.36%
Return on Capital (ROIC)	-55.53%
Revenue Per Employee	$20,682
Profits Per Employee	-$1.15M
Employee Count	88
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, LYRA has paid $59,000 in taxes.

Income Tax	59,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.57% in the last 52 weeks. The beta is -0.04, so LYRA's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-91.57%
50-Day Moving Average	0.26
200-Day Moving Average	2.12
Relative Strength Index (RSI)	52.67
Average Volume (20 Days)	1,447,233

Short Selling Information

The latest short interest is 2.14 million, so 3.27% of the outstanding shares have been sold short.

Short Interest	2.14M
Short Previous Month	2.85M
Short % of Shares Out	3.27%
Short % of Float	5.13%
Short Ratio (days to cover)	3.65

Income Statement

In the last 12 months, LYRA had revenue of $1.82 million and -$101.39 million in losses. Loss per share was -$1.64.

Revenue	1.82M
Gross Profit	-54.32M
Operating Income	-74.63M
Pretax Income	-68.82M
Net Income	-101.39M
EBITDA	-74.34M
EBIT	-74.63M
Loss Per Share	-$1.64

Full Income Statement

Balance Sheet

The company has $67.50 million in cash and $36.75 million in debt, giving a net cash position of $30.75 million or $0.47 per share.

Cash & Cash Equivalents	67.50M
Total Debt	36.75M
Net Cash	30.75M
Net Cash Per Share	$0.47
Equity (Book Value)	30.98M
Book Value Per Share	0.47
Working Capital	50.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.61 million and capital expenditures -$3.28 million, giving a free cash flow of -$78.88 million.

Operating Cash Flow	-75.61M
Capital Expenditures	-3.28M
Free Cash Flow	-78.88M
FCF Per Share	-$1.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4,100.71%
Pretax Margin	-5,567.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,348.81%

Dividends & Yields

LYRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.70%
Shareholder Yield	-60.70%
Earnings Yield	-589.18%
FCF Yield	-458.40%

Analyst Forecast

The average price target for LYRA is $4.50, which is 1,611.68% higher than the current price. The consensus rating is "Buy".

Price Target	$4.50
Price Target Difference	1,611.68%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	141.11%
EPS Growth Forecast (5Y)	-19.22%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYRA has an Altman Z-Score of -5.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.76
Piotroski F-Score	3